Clinical trial
Drug Interaction Study Between Antimalarial and Anti-HIV Medications
NCT00266058 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00266058 |
|---|---|
| Title | Drug Interaction Study Between Antimalarial and Anti-HIV Medications |
| Official title | Pharmacokinetic Interactions Between Antiretroviral Agents, Lopinavir/Ritonavir and Efavirenz and Antimalarial Drug Combination, Artemether/Lumefantrine |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, Malaria |
| Intervention type | Drug |
| Interventions | Lopinavir/Ritonavir, Efavirenz, Artemether/lumefantrine |
| Enrollment | 33 |
| Start date | Dec 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Dec 15, 2005 |
| Last update posted | Jun 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: